PATTERNS OF TREATMENT ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING LINAGLIPTIN AND OTHER NON-INSULIN DIABETES MEDICATIONS (NIDMS)

被引：0
|
作者：
Patorno, E. [1 ,2 ]
Gopalakrishnan, C. [1 ,2 ]
Zorina, O. [3 ]
Schneeweiss, S. [1 ,2 ]
Bartels, D. [3 ]
Seeger, J. D. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.335
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB28
引用
收藏
页码：A57 / A57
页数：1
相关论文
共 50 条
  • [1] Characteristics and Medication Adherence of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Linagliptin and Other Diabetes Medications (Noninsulin) in Routine Care
    Patorno, Elisabetta
    Gopalakrishnan, Chandrasekar
    Zorina, Olesya
    Schneeweiss, Sebastian
    Bartels, Dorothee
    Liu, Jun
    Seeger, John
    DIABETES, 2015, 64 : A443 - A443
  • [2] ADHERENCE AND PERSISTENCE IN PATIENTS INITIATING TREATMENT WITH INJECTABLE THERAPIES FOR TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN
    Sicras-Mainar, A.
    Navarro, R.
    Ruiz, L.
    Morano, R.
    VALUE IN HEALTH, 2015, 18 (07) : A612 - A612
  • [3] Treatment Persistence and Switch in German Patients with Type 2 Diabetes Mellitus (T2DM) after Initiating Basal Insulin
    Chou, Engels
    Dippel, Franz-Werner
    Chung, Hsing-Wen
    DIABETES, 2014, 63 : A403 - A403
  • [4] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    DIABETES, 2014, 63 : A307 - A307
  • [5] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
    Ross, Stuart A.
    Haak, Thomas
    Patel, Sanjay
    Thiemann, Sandra
    Schumacher, Helmut
    Meinicke, Thomas
    DIABETES, 2014, 63 : A277 - A277
  • [6] Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus
    Yandrapalli, Srikanth
    Jolly, George
    Horblitt, Adam
    Sanaani, Abdallah
    Aronow, Wilbert S.
    POSTGRADUATE MEDICINE, 2017, 129 (08) : 811 - 821
  • [7] Adherence to Insulin Therapy Assistance Program (iTAP) among Indian Type 2 Diabetes Mellitus (T2DM) Patients
    Raj, Praveen
    Pawar, Dilip
    Jabeen, Sarah
    Shivaram, V. S.
    DIABETES, 2018, 67
  • [8] Real-world treatment switching patterns in patients (pts) with type 2 diabetes mellitus (T2DM) on basal insulin (INS)
    Kapustin, J.
    Anderson, J. E.
    Reid, T.
    Rhinehart, A.
    Brunton, S.
    Stewart, J.
    Zhou, W.
    Dex, T.
    Kazemi, M.
    Vlajnic, A.
    Dalal, M.
    DIABETOLOGIA, 2014, 57 : S440 - S440
  • [9] Effects of Insulin Adherence and Delivery Device on Real World Outcomes Among Patients With Type 2 Diabetes Mellitus (T2DM)
    Ayyagari, Rajeev
    Wei, Wenhui
    Cheng, David
    Pan, Chunshen
    Wu, Eric Q.
    DIABETES, 2013, 62 : A327 - A327
  • [10] USE OF HEDIS A1C TARGETS IN CHARACTERIZING TREATMENT GOALS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING BASAL INSULIN
    Oster, G.
    Moen, D.
    Yang, T.
    Dalal, M.
    Kazemi, M.
    Sung, J. C.
    Traylor, L.
    Sullivan, S. D.
    VALUE IN HEALTH, 2015, 18 (03) : A70 - A70
12345